About
Allterum Therapeutics is a biopharmaceutical company developing therapies targeting the IL-7 pathway for CD127-expressing cancers, including relapsed or refractory T-cell acute lymphoblastic leukemia and B-cell hematologic malignancies.
Explore Allterum Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.